The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The Science Underlying COVID-19: Implications for the Cardiovascular System
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has affected health and economy worldwide on an unprecedented scale. Patients have diverse clinical outcomes, but those with preexisting cardiovascular disease, hypertension, and related conditions incur disproportionately worse outcome. The high infectivity of severe acute respiratory syndrome coronavirus 2 is in part related to new mutations in the receptor binding domain, and acquisition of a furin cleavage site in the S-spike protein. The continued viral shedding in the asymptomatic and presymptomatic individuals enhances its community transmission. The virus uses the angiotensin converting enzyme 2 receptor for internalization, aided by transmembrane protease serine 2 protease. The tissue localization of the receptors correlates with COVID-19 presenting symptoms and organ dysfunction. Virus-induced angiotensin converting enzyme 2 downregulation may attenuate its function, diminish its anti-inflammatory role, and heighten angiotensin II effects in the predisposed patients. Lymphopenia occurs early and is prognostic, potentially associated with reduction of the CD4+ and some CD8+ T cells. This leads to imbalance of the innate/acquired immune response, delayed viral clearance, and hyperstimulated macrophages and neutrophils. Appropriate type I interferon pathway activation is critical for virus attenuation and balanced immune response. Persistent immune activation in predisposed patients, such as elderly adults and those with cardiovascular risk, can lead to hemophagocytosis-like syndrome, with uncontrolled amplification of cytokine production, leading to multiorgan failure and death. In addition to the airways and lungs, the cardiovascular system is often involved in COVID-19 early, reflected in the release of highly sensitive troponin and natriuretic peptides, which are all extremely prognostic, in particular, in those showing continued rise, along with cytokines such as interleukin-6. Inflammation in the vascular system can result in diffuse microangiopathy with thrombosis. Inflammation in the myocardium can result in myocarditis, heart failure, cardiac arrhythmias, acute coronary syndrome, rapid deterioration, and sudden death. Aggressive support based on early prognostic indicators with expectant management can potentially improve recovery. Appropriate treatment for heart failure, arrhythmias, acute coronary syndrome, and thrombosis remain important. Specific evidence-based treatment strategies for COVID-19 will emerge with ongoing global collaboration on multiple approaches being evaluated. To protect the wider population, antibody testing and effective vaccine will be needed to make COVID-19 history.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Self-citationTian, H., Liu, Y., Li, Y., Wu, C.-H., Chen, B., Kraemer, M. U. G., Li, B., Cai, J., Xu, B., Yang, Q., et al. (2020) · Science · doi:10.1126/science.abb6105 · Cited by 2,010
Covid-19 — Navigating the Uncharted
Fauci, A. S., Lane, H. C., & Redfield, R. R. (2020) · New England Journal of Medicine · doi:10.1056/nejme2002387 · Cited by 1,969
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Inciardi, R. M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., Cani, D. S., Cerini, M., Farina, D., Gavazzi, E., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1096 · Cited by 1,858
Evolution of the immune system in humans from infancy to old age
Simon, A. K., Hollander, G. A., & McMichael, A. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.3085 · Cited by 1,796
COVID-19 and cardiovascular disease
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., Burkhoff, D., Kumaraiah, D., Rabbani, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046941 · Cited by 1,738
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Matsuyama, S., Nao, N., Shirato, K., Kawase, M., Saito, S., Takayama, I., Nagata, N., Sekizuka, T., Katoh, H., Kato, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002589117 · Cited by 1,411
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Kwong, J. C., Schwartz, K. L., Campitelli, M. A., Chung, H., Crowcroft, N. S., Karnauchow, T., Katz, K., Ko, D. T., McGeer, A. J., McNally, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1702090 · Cited by 1,199
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P., & Zhang, Y. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa150 · Cited by 1,131
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & Butany, J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 893
Self-citationCao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., Huang, X., Ning, G., & Wang, W. (2020) · Cell Discovery · doi:10.1038/s41421-020-0147-1 · Cited by 865
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Self-citationSchultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Self-citationLippi, G., Lavie, C. J., & Sanchis-Gomar, F. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.03.001 · Cited by 714
Role of innate and adaptive immune mechanisms in cardiac injury and repair
Epelman, S., Liu, P. P., & Mann, D. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3800 · Cited by 634
Self-citationAssociation of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
Bonow, R. O., Fonarow, G. C., O’Gara, P. T., & Yancy, C. W. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1105 · Cited by 594
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G., Griffiths, E., Krawczyk, C., Richardson, C. D., Aitken, K., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 562
Self-citationWong, R. S. M., Wu, A., To, K. F., Lee, N., Lam, C. W. K., Wong, C. K., Chan, P. K. S., Ng, M. H. L., Yu, L. M., Hui, D. S., et al. (2003) · BMJ · doi:10.1136/bmj.326.7403.1358 · Cited by 561
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Channappanavar, R., Fehr, A. R., Zheng, J., Wohlford-Lenane, C., Abrahante, J. E., Mack, M., Sompallae, R., McCray, P. B., Meyerholz, D. K., & Perlman, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126363 · Cited by 556
Hemophagocytic Syndromes and Infection
Fisman, D. N. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0606.000608 · Cited by 548
Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.279206 · Cited by 516
Tracking virus outbreaks in the twenty-first century
Grubaugh, N. D., Ladner, J. T., Lemey, P., Pybus, O. G., Rambaut, A., Holmes, E. C., & Andersen, K. G. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0296-2 · Cited by 485
Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
Wu, Q., Zhou, L., Sun, X., Yan, Z., Hu, C., Wu, J., Xu, L., Li, X., Liu, H., Yin, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09536-z · Cited by 439
Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2010) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 399
Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., Pöhlmann, S., & Soilleux, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035876 · Cited by 398
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A. F., & Osswald, S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa235 · Cited by 395
Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques
Haagmans, B. L., Kuiken, T., Martina, B. E., Fouchier, R. A. M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., de Jong, T., Itamura, S., Chan, K.-H., et al. (2004) · Nature Medicine · doi:10.1038/nm1001 · Cited by 381
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
Grimaud, M., Starck, J., Levy, M., Marais, C., Chareyre, J., Khraiche, D., Leruez-Ville, M., Quartier, P., Léger, P. L., Geslain, G., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00690-8 · Cited by 319
The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity
Pavlovich, S. S., Lovett, S. P., Koroleva, G., Guito, J. C., Arnold, C. E., Nagle, E. R., Kulcsar, K., Lee, A., Thibaud-Nissen, F., Hume, A. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.070 · Cited by 278
Angiotensin Converting Enzyme 2: A Double-Edged Sword
Wang, K., Gheblawi, M., & Oudit, G. Y. (2020) · Circulation · doi:10.1161/circulationaha.120.047049 · Cited by 265
He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., & Dwyer, D. E. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.014 · Cited by 258
The Role of ACE2 in Cardiovascular Physiology
Oudit, G. Y., Crackower, M. A., Backx, P. H., & Penninger, J. M. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00233-5 · Cited by 254
Thomas, M. C., Pickering, R. J., Tsorotes, D., Koitka, A., Sheehy, K., Bernardi, S., Toffoli, B., Nguyen-Huu, T.-P., Head, G. A., Fu, Y., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.219279 · Cited by 232
Ye, M., Wysocki, J., Naaz, P., Salabat, M. R., LaPointe, M. S., & Batlle, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000126192.27644.76 · Cited by 221
Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications
Soro-Paavonen, A., Gordin, D., Forsblom, C., Rosengard-Barlund, M., Waden, J., Thorn, L., Sandholm, N., Thomas, M. C., & Groop, P.-H. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f04b6 · Cited by 208
High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19
Chapman, A. R., Bularga, A., & Mills, N. L. (2020) · Circulation · doi:10.1161/circulationaha.120.047008 · Cited by 184
Fuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., Yeh, W.-C., Akira, S., & Liu, P. P. (2005) · Circulation · doi:10.1161/circulationaha.105.536433 · Cited by 181
Self-citationThe tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease
Liu, P., Aitken, K., Kong, Y.-Y., Opavsky, M. A., Martino, T., Dawood, F., Wen, W.-H., Kozieradzki, I., Bachmaier, K., Straus, D., et al. (2000) · Nature Medicine · doi:10.1038/74689 · Cited by 174
Self-citationEndothelial Dysfunction in Sepsis
Helms, J., Kremer, H., Schini‐Kerth, V. B., & Meziani, F. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111311020005 · Cited by 145
Scheuplein, V., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara‐Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 132
Shi, Y., Fukuoka, M., Li, G., Liu, Y., Chen, M., Konviser, M., Chen, X., Opavsky, M. A., & Liu, P. P. (2010) · Circulation · doi:10.1161/circulationaha.109.893248 · Cited by 125
Self-citationCOVID-19: from epidemiology to treatment
Pericàs, J. M., Meneses, M. H., Sheahan, T. P., Quintana, E., Ambrosioni, J., Sandoval, E., Falces, C., Marcos, M. Á., Tuset, M., Vilella, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa462 · Cited by 122
Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
Xu, M. M., Liu, P. P., & Li, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00065.2017 · Cited by 107
Self-citationKatalin, Ú., Fagyas, M., Siket, I. M., Kertész, A., Csanádi, Z., Sándorfi, G., Clemens, M., Fedor, R., Papp, Z., Edes, I. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087845 · Cited by 92
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis
Opavsky, M. A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J., & Liu, P. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213971 · Cited by 91
Self-citationBradycardia in Patients With COVID-19: A Calm Before the Storm?
Amaratunga, E. A. D. T., Corwin, D. S., Moran, L. N., & Snyder, R. H. (2020) · Cureus · doi:10.7759/cureus.8599 · Cited by 91
Initial Precipitants and Recurrence of Atrial Fibrillation
Wang, E. Y., Hulme, O. L., Khurshid, S. S., Weng, L.-C. C., Choi, S. H., Walkey, A. J., Ashburner, J. M., McManus, D. D., Singer, D. E., Atlas, S. J., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007716 · Cited by 87
Fagyas, M., Katalin, Ú., Siket, I. M., Fülöp, G. Á., Csató, V., Daragó, A., Boczán, J., Bányai, E., Szentkirályi, I., Maros, T. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087844 · Cited by 61
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice
Pedersen, K. B., Chodavarapu, H., Porretta, C. P., Robinson, L. K., & Lazartigues, E. D. (2015) · Endocrinology · doi:10.1210/en.2015-1556 · Cited by 51
Valaperti, A., Nishii, M., Liu, Y., Naito, K., Chan, M., Zhang, L., Skurk, C., Schultheiß, H., Wells, G. A., Eriksson, U., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002275 · Cited by 50
Self-citationBanerjee, A., Falzarano, D., Rapin, N., Lew, J. M., & Misra, V. (2019) · Viruses · doi:10.3390/v11020152 · Cited by 49
Acosta‐Ramírez, E., Pérez‐Flores, R., Majeau, N., Pastelin‐Palacios, R., Gil‐Cruz, C., Ramírez‐Saldaña, M., Manjarrez‐Orduño, N., Cervantes‐Barragán, L., Santos‐Argumedo, L., Flores‐Romo, L., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02753.x · Cited by 47
The microcirculation as a diagnostic and therapeutic target in sepsis
Nencioni, A., Trzeciak, S. W., & Shapiro, N. I. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0297-5 · Cited by 40
Temgoua, M. N., Kuate, L. M., Ngatchou, W., Sibetcheu, A. T., Toupendi, Z. N., Belobo, G., Ossa, A., & Kingué, S. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.35.2.22947 · Cited by 8
Cited by
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Hyperinflammatory shock in children during COVID-19 pandemic
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31094-1 · Cited by 2,494
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Metadata
- Authors
- Liu, P. P., Blet, A., Smyth, D., & Li, H.
- Venue
- Circulation
- Published
- 2020-07-07
- Volume
- 142
- Issue
- 1
- Pages
- 68-78
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3015438945
- Cited by
- 800
- References
- 73
- FWCI
- 21.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.